Skip to content

This study aimed to determine the effects of insulin injection site and interval timing to the control of postprandial glucose in diabetes mellitus patients type 2

Effect of Insulin Injection Site and Time Interval Administration for the Postprandial Glucose Control in Patient with Diabetes Type 2

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT2017062134690N1
Enrollment
60
Registered
2017-07-12
Start date
2015-05-01
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patient with diabetes type 2. Non-insulin-dependent diabetes mellitus

Interventions

Intervention 1: Intervention I/Block I: Insulin injections in the abdomen, deltoid, thigh and gluteus at the time of administration were 0 minutes (along with meals). Types of insulin administered was
Treatment - Other
Intervention I/Block I: Insulin injections in the abdomen, deltoid, thigh and gluteus at the time of administration were 0 minutes (along with meals). Types of insulin administered was Rapid-acting in
Intervention II/Block II: Insulin injections in the abdomen, deltoid, thigh and gluteus at the time of administration were 10 minutes before meal. Types of insulin administered was Rapid-acting insuli
Intervention III/Block III: Insulin injections in the abdomen, deltoid, thigh and gluteus at the time of administration were 20 minutes before meal. Types of insulin administered was Rapid-acting insu
Intervention IV/Block IV: Insulin injections in the abdomen, deltoid, thigh and gluteus at the time of administration were 30 minutes before meal. Types of insulin administered was Rapid-acting insuli

Sponsors

Agus Santosa
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 80 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: Patient diabetes melitus type2; Age min 40 years old; used insulin therapy, Exclusion criteria: Patient diabetes melitus type2 with complication diabetic (neuropati diabetic, retinopati diabetic, nefropati diabetic); Hiperosmolalitas ketoasidosi; Used Oral Antihyperglycemic Drugs

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Postprandial glucose. Timepoint: 2 hour postprandial. Method of measurement: Glucometer.

Secondary

MeasureTime frame
Time Interval Administration. Timepoint: 0-30 minutes. Method of measurement: timer.

Countries

Indonesia

Contacts

Public ContactIkhsan Mujahid

Universitas Muhammadiyah Purwokerto

info@ump.ac.id+620281636751

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026